Welcome to Anagrammer Crossword Genius! Keep reading below to see if tramicro is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on tramicro.
tramicro
Searching in Crosswords ...
The answer TRAMICRO has 0 possible clue(s) in existing crosswords.
Searching in Word Games ...
The word TRAMICRO is NOT valid in any word game. (Sorry, you cannot play TRAMICRO in Scrabble, Words With Friends etc)
There are 8 letters in TRAMICRO ( A1C3I1M3O1R1T1 )
To search all scrabble anagrams of TRAMICRO, to go: TRAMICRO?
Rearrange the letters in TRAMICRO and see some winning combinations
Scrabble results that can be created with an extra letter added to TRAMICRO
5 letters out of TRAMICRO
4 letters out of TRAMICRO
3 letters out of TRAMICRO
Searching in Dictionaries ...
Definitions of tramicro in various dictionaries:
No definitions found
Word Research / Anagrams and more ...
Keep reading for additional results and analysis below.
| Tramicro might refer to |
|---|
| Homotaurine (3-amino-1-propanesulfonic acid (3-APS) or tramiprosate (INN)) is a natural organic compound found in seaweed. It is analogous to taurine, but with an extra carbon in its chain. It has GABAergic activity, apparently by mimicking GABA, which it resembles.In a phase 2 study Homotaurine reduced Abeta(42) levels a type of amyloid beta (Abeta), a toxic protein known to aggregate, leading to amyloid plaque deposition in the brain.In 2012 Homotaurine was investigated in a Phase III clinical trial as a potential treatment for Alzheimer's disease that did not show efficacy in its primary endpoints but did show positive and significant effects of homotaurine on secondary endpoints and subgroups of patients, including a reduction in hippocampal volume loss and lower decline in memory function in the overall cohort, as well as a reduction in global cognitive decline in APOE4 allele carriers, suggesting a disease-modifying effects.October 24, 2017 The FDA Granted Fast Track Designation to Alzheon’s ALZ-801 Development Program for the Treatment of Alzheimer’s Disease.In 2018 a new phase 3 study for genetically-defined subpopulation of high risk patients who are homozygous for the ε4 allele of apolipoprotein E (APOE4/4 homozygotes) at the Mild stage of AD has been filed with the FDA under the name ALZ-801 by the drug company Alzheon.It is approved by Canada's FDA to sell as a dietary supplement.It is approved in Israel as a dietary supplement. |